Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Wednesday, 04 March 2026 12:00 AM EOD	Asian-Paints2285.65	Hind-Unilever2262.65	ITC312.00	Trent3755.35	Larsen-and-Toubro3882.15	M-and-M3263.95	Reliance-Industries1345.55	Tata-Steel196.65	Titan-Company4209.70	SBI1174.50	Bharat-Electron446.70	Kotak-Mah-Bank403.20	Infosys1307.50	Bajaj-Finance945.00	Sun-PharmaInds1749.35	HDFC-Bank868.40	TCS2587.35	ICICI-Bank1364.50	Power-Grid-Corpn291.70	Maruti-Suzuki14152.45	Axis-Bank1351.05	HCL-Technologies1364.00	NTPC365.85	Bharti-Airtel1906.75	Tech-Mahindra1350.60	Adani-Ports1434.25	UltraTech-Cem12105.35	Bajaj-Finserv1889.15	Interglobe-Aviat4392.70	Eternal240.70
15 mins delay SENSEX 79,116.19 [-1,122.66]	-21.95 -0.95%	-57.15 -2.46%	-2.80 -0.89%	-90.95 -2.36%	-184.30 -4.53%	-70.80 -2.12%	-12.80 -0.94%	-14.25 -6.76%	-59.65 -1.40%	-14.90 -1.25%	-7.05 -1.55%	-9.80 -2.37%	19.35 1.50%	-32.90 -3.36%	-3.35 -0.19%	-13.35 -1.51%	-25.85 -0.99%	-9.70 -0.71%	-5.00 -1.69%	-228.15 -1.59%	-22.10 -1.61%	-6.75 -0.49%	-11.60 -3.07%	33.40 1.78%	5.85 0.44%	-35.95 -2.45%	-410.35 -3.28%	-54.80 -2.82%	-128.70 -2.85%	-2.35 -0.97%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Aarti Drugs gains as arm incorporates step-down subsidiary in Chile

04-Mar-26 15:00Hrs IST

With this incorporation, Tripharma Chile SpA becomes a step-down subsidiary of Aarti Drugs. The newly formed entity has been established to market formulation drugs and participate in government tenders as well as the private pharmaceutical market in Chile. The business activities of the new subsidiary are aligned with those of its holding companies.

The cost of subscription stands at 1,000,000 Chilean pesos towards share capital contribution, comprising 1,000,000 shares. The entire share capital of Tripharma Chile SpA will be held by Pinnacle Chile SpA, making it a wholly owned step-down subsidiary of the company.

Aarti Drugs was established in the year 1984 and forms part of the $6 billion Aarti Group of Industries. The company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates and speciality chemicals and produces formulations with its wholly-owned subsidiary, Pinnacle Life Science.

The company reported a 9.4% increase in consolidated net profit to Rs 40.54 crore on an 8.1% rise in net sales to Rs 601.71 crore in Q3 FY26 as compared with Q3 FY25.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise